Sun Yat-sen University: Neoplasms trials

The registry lists 26 Neoplasms studies with Sun Yat-sen University as lead sponsor. 10 are open to participants now and 1 have results posted.

Phase 1 6Phase 2 7Phase 3 4Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• HR20013 for the Prevention of Nausea and Vomiting in Patients With Cancer: A Real-World StudyRecruitingNCT07874308
• Multi-Theory Model-Based AI Agent Intervention for Smoking Cessation in Early-Stage Cancer PatientsNot yet recruitingNCT07827066Not applicable
• Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal CancerNot yet recruitingNCT07405736Phase 2
• A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid TumorsRecruitingNCT07269899Phase 1
• Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in ChildrenRecruitingNCT07188311Not applicable
• Evaluation of WGc-043 Injection in Advanced Solid Tumors: Phase I StudyNot yet recruitingNCT07028047Phase 1
• UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid TumorsRecruitingNCT06760117Phase 1
• Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLMRecruitingNCT06208371Phase 3
• Preoperative Systemic Therapy for Colorectal Cancer Peritoneal MetastasesNot yet recruitingNCT05353582Phase 2
• Assessment of Early-detection Based on Liquid Biopsy in Lymphoid MalignanciesRecruitingNCT05275036
• Icotinib for Completed Resected IB NSCLC With EGFR MutationCompletedNCT02264210Phase 2Results posted
• Artificial Intelligence-assisted Screening of Malignant Pigmented Tumors on the Ocular SurfaceCompletedNCT05645341
• Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid TumorsActive, not recruitingNCT05620862Phase 1
• The Association Between Watching Mukbang Videos and the Appetite of Children With CancerCompletedNCT05493020
• Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and ChemoradiotherapyStatus unknownNCT04507035Phase 4
• Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant TumorsStatus unknownNCT04400851Phase 1
• Prospective Screening Programme for Malignant TumorsStatus unknownNCT04230200
• IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.Status unknownNCT03854838Phase 2
• GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03840421Phase 3
• Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal CarcinomaStatus unknownNCT03837808Phase 3
• Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma PatientsCompletedNCT02604472
• Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal CarcinomaStatus unknownNCT02211677
• Maintenance Treatment With Capecitabine in Colorectal Cancer PatientsStatus unknownNCT02027363Phase 2
• Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric CancerCompletedNCT02004769Phase 2
• Real-time Cancer Pain Assessment and InterventionStatus unknownNCT01914107Phase 2/3
• Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid TumorStatus unknownNCT00262327Phase 1